phase 1
ii 1
trial 1
evaluate 1
efficacy 1
fostamatinib 1
patients 2
relapsed 1
refractory 1
diffuse 1
large 1
bcell 1
lymphoma 1
dlbcl 1
bruton 1
tyrosine 1
kinase 1
inhibitor 1
ibrutinib 1
chemoimmunotherapy 1
chronic 1
lymphocytic 1
leukemia 1
